small molecule

AMPICILLIN AND SULBACTAM

AMPICILLIN SODIUM; SULBACTAM SODIUM

Loss of exclusivity—loss of exclusivity

CompanyHQ SPECIALTY PHARMA CORP

Drug detail

Brand name	AMPICILLIN AND SULBACTAM
Active ingredient	AMPICILLIN SODIUM; SULBACTAM SODIUM
Strength	EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL
Dosage form	INJECTABLE
Route	INJECTION
Modality	Small molecule
FDA approval	November 2005
Marketing status	RX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.